Britain, Government, Health, Politics, Society

NHS at 70: The Health Service faces tough choices to survive

THE NATIONAL HEALTH SERVICE

Intro: The NHS is creaking under the strain of an ageing and unfit population

The natural lifespan of a human being was once viewed as being three score years and ten. But while a baby girl born in 1948 could reasonably look forward to a life that long, the life expectancy of a boy was less than 66.

How times have changed. Today, the respective figures for either gender are about 10 years longer, thanks in large part to the National Health Service which turned 70 on the 5 July.

Among its major achievements, the NHS has saved countless lives from infection or injury, eliminated horrific diseases like polio from the UK, introduced comprehensive vaccination programmes, and enabled the birth of the world’s first IVF baby. It has many other successes to its name.

NHS staff have become the heroes of modern-day Britain: nurses were last year voted the most trusted profession, with doctors a close second. Nurse Pauline Cafferkey, who contracted Ebola while working in Sierra Leone, recently told of how she was “astounded” by the level of care she received, with medical staff “putting their lives on hold and working round the clock” to save her.

And she is certainly not alone. The Commonwealth Fund, a US think tank, last year ranked the NHS as the best healthcare system in 11 leading countries, including the US, France, Germany and Australia.

The UK’s total spending on public and private healthcare is about 10 per cent of national income. This is lower than in the US (16%), as well as Japan, France and Germany (11%). The simple comparisons would suggest we are getting a top-class health service on the cheap; indeed, the NHS has been described in the British Medical Journal as the “world’s most cost-effective healthcare system.”

Yet, for all that, the NHS is clearly showing signs of decrepitude as it moves on from its 70th anniversary. Its success at enabling the average person to live an extra decade has created a vast amount of new work to keep the diseases of old age at bay. Meanwhile, poor trends of bad diets and physical inactivity have produced a surge in rates of obesity and associated illnesses, some of which are threatening to overwhelm the NHS.

While healthcare funding has been increased by both Labour and Conservative governments, the extra cash has failed to keep pace with the rise in demand, leaving doctors and nurses increasingly overworked and stressed as waiting times for treatment have increased.

However, whilst governments and health secretaries can change, we, the public, must share some of the blame. Most people bang the table to demand appointments and yet a staggering 1.7million, about 10 per cent, of them were missed over the last decade at a cost of some £200million. Many also insist on antibiotics when they are not needed.

If we wish the NHS to continue as part of the societal fabric of the UK, then some tough choices may need to be made. And, on this, the public may be more accepting of the need for change than politicians realise.

A recent poll found 75 per cent of respondents backed fining patients who repeatedly missed appointments. Plastic surgery for purely cosmetic reasons and other non-vital procedures may need to be cut or scrapped completely.

Laws that were enacted in applying a 5p charge for plastic bags resulted in an 80-90 per cent fall in their use. So, unless we can be persuaded to stop putting so much pressure on the NHS, perhaps the time has come to consider small charges for prescriptions and even GP appointments to make us all value them more.

For if the NHS is ever lost, we will rue the day we lost sight of just how worthwhile it is.

Standard
Medical, Research, Science

The availability of cheap drugs offers hope for dementia sufferers

DEMENTIA

SCIENTISTS in Scotland have found a potential cure for the most common cause of dementia and strokes in old people – using cheap, everyday drugs.

Human trials are already being carried out after rats were treated with a combination of cilostazol and isosorbide mononitrate.

Researchers say once trials are complete they could be available to patients within two years.

The breakthrough comes days after new figures showed Scotland is facing a dementia “timebomb” as experts warn conditions such as Alzheimer’s will soon overtake heart disease as the biggest killer.

The drugs involved in the latest study repaired the deterioration of blood vessels in rats’ brains associated with a condition called cerebral small vessel disease, or SVD, and reversed the symptoms.

SVD is responsible for almost half of all dementia cases in the UK and accounts for one in five strokes. It can also aggravate the symptoms of Alzheimer’s disease.

Professor Anna Williams, group leader at Edinburgh University’s Medical Research Council (MRC) Centre for Regenerative Medicine, said: “We are very excited because it is the first time we have really got to the bottom of why this disease called cerebral small vessel disease happens.

“We gave rats some drugs that made the cells happier and managed to reverse the changes in the brain. We have found a way to reverse it. That is exciting for people with dementia.”

Professor Williams added: “The nice things about these drugs is that they are already tested on people, they are cheap and readily available so can quickly be given to people.”

Cilostazol and isosorbide mononitrate are commonly used by patients with heart and blood pressure ailments. Pills are available for around 60p and 20p respectively.

The research team discovered that SVD occurs when cells that line the small blood vessels in the brain become dysfunctional. This causes them to secrete a molecule into the brain, which stops production of myelin, a protective layer that surrounds brain cells, leading to brain damage. The drugs prevent this.

Experts hailed the breakthrough. A spokesperson for the charity Age Scotland, said: “Any development of this nature and any measures to combat dementia is good news indeed.”

The research, first published in Science Translational Medicine, was carried out at the MRC centre and the UK Dementia Research Institute at Edinburgh University. It was funded by the MRC, Alzheimer’s Research UK and the private Leducq Foundation, based in Paris.

Dr Sara Imarisio, head of research at Alzheimer’s Research UK, said: “The findings highlight a promising direction for research into treatments that could limit the damaging effects of blood vessel changes and help keep nerve cells functioning for longer.”

Researchers say further studies will be needed to test whether the treatment also works once the disease is firmly established, but trials will be over within a year.

Estimates indicate there are almost 47 million people living with dementia worldwide and the numbers affected are expected to double every 20 years, rising to more than 115 million by 2050.

Standard
China, Economic, European Union, Government, Politics, Society, United States

Trump’s trade war is a risk to the global economy

GLOBAL TRADE WAR

AN escalating trade war between China, the US and Europe could plunge the global economy into turmoil, international experts have warned.

The World Trade Organisation (WTO) said the battle of wills between President Donald Trump and rivals in China and the European Union has put “economic recovery in jeopardy”.

In a major report on the 20 largest economies – known as the G20 – WTO economists warn that angry rhetoric and rising tariffs on all sides are a severe threat.

The WTO said that G20 countries slapped £52.6billion of sanctions on trade between October and May. A total of 39 new restrictive measures were introduced to block goods from competitors – double the number in the previous report.

The WTO said: “The G20 economies must use all means at their disposal to de-escalate the situation and promote further trade recovery.”

President Trump vowed on the campaign trail to protect US jobs and industries from globalisation. He has imposed aluminium and steel tariffs on China and the EU, and hit the Chinese with extra duties on everything from bulldozers to touchscreens.

Beijing responded in kind, hitting key US exports such as its important soya bean trade. Meanwhile, Brussels has slapped tariffs on American goods, including motorcycles and bourbon whiskey.

The President is now threatening to act against Europe’s prized car manufacturers. Last week, he said: “The EU is possibly as bad as China, only smaller. They send a Mercedes in, we can’t send our cars in.”

Standard